BMS Opdivo+Yervoy combo received USFDA new indication approval.
Posted on15 Jul 2018
Comments0
Bristol-Myers Squibb Company announced that its Opdivo (nivolumab) 3 mg/kg plus low-dose Yervoy (ipilimumab) 1 mg/kg (injections for intravenous use) has received... Read More